ALT logo

Altimmune, Inc. (ALT) CAPEX

annual CAPEX:

N/A
December 31, 2024

Summary

  • ALT annual capital expenditures is not available.

Performance

1-year change

-

3-year change

-

5-year change

-

15-year change

-

ALT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$12.31M
ALT annual capital expenditures is currently at an all-time high

3-year low

$47.00K
ALT annual capital expenditures is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
ALT previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
ALT next annual earnings announcement has not yet been scheduled

OtherALTcash flow metrics

annual FCF

-$79.85M
ALT annual free cash flow is -$79.85 million

annual CFO

-$79.85M
ALT annual cash flow from operations is -$79.85 million

annual CFI

-$28.39M
ALT annual cash flow from investing activities is -$28.39 million

annual CFF

$10.04M
ALT annual cash flow from financing activities is $10.04 million

quarterly CAPEX:

N/A
March 1, 2025

Summary

  • ALT quarterly capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

ALT quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$7.77M
ALT quarterly capital expenditures is currently at an all-time high

3-year low

-$4000.00
ALT quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
ALT previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Aug 8, 2025
ALT next earnings announcement is scheduled for Aug 8, 2025

OtherALTcash flow metrics

quarterly FCF

-$16.84M
ALT quarterly free cash flow is -$16.84 million

quarterly CFO

-$16.84M
ALT quarterly cash flow from operations is -$16.84 million

quarterly CFI

-$5.10M
ALT quarterly cash flow from investing activities is -$5.10 million

quarterly CFF

$34.12M
ALT quarterly cash flow from financing activities is $34.12 million

TTM CAPEX:

N/A
March 1, 2025

Summary

  • ALT TTM capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

ALT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$12.31M
ALT TTM capital expenditures is currently at an all-time high

3-year low

$47.00K
ALT TTM capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
ALT previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Aug 8, 2025
ALT next earnings announcement is scheduled for Aug 8, 2025

OtherALTcash flow metrics

TTM FCF

-$80.33M
ALT TTM free cash flow is -$80.33 million

TTM CFO

-$80.33M
ALT TTM cash flow from operations is -$80.33 million

TTM CFI

$6.03M
ALT TTM cash flow from investing activities is $6.03 million

TTM CFF

$44.42M
ALT TTM cash flow from financing activities is $44.42 million

ALT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

ALT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

ALT CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$47.00K(-62.7%)
$0.00(0.0%)
$47.00K(-44.7%)
Sep 2023
-
$0.00(-100.0%)
$85.00K(-41.4%)
Jun 2023
-
-$4000.00(-107.8%)
$145.00K(-13.7%)
Mar 2023
-
$51.00K(+34.2%)
$168.00K(+33.3%)
Dec 2022
$126.00K(-99.0%)
$38.00K(-36.7%)
$126.00K(-47.5%)
Sep 2022
-
$60.00K(+215.8%)
$240.00K(-18.6%)
Jun 2022
-
$19.00K(+111.1%)
$295.00K(-96.3%)
Mar 2022
-
$9000.00(-94.1%)
$8.05M(-34.6%)
Dec 2021
$12.31M(+3495.8%)
$152.00K(+32.2%)
$12.31M(+0.1%)
Sep 2021
-
$115.00K(-98.5%)
$12.30M(+0.3%)
Jun 2021
-
$7.77M(+82.0%)
$12.27M(+168.1%)
Mar 2021
-
$4.27M(+2882.5%)
$4.58M(+1236.4%)
Dec 2020
$342.40K(+1080.7%)
$143.20K(+80.6%)
$342.40K(+69.8%)
Sep 2020
-
$79.30K(-3.8%)
$201.60K(+53.0%)
Jun 2020
-
$82.40K(+119.7%)
$131.80K(+111.6%)
Mar 2020
-
$37.50K(+1462.5%)
$62.30K(+114.8%)
Dec 2019
$29.00K(-97.1%)
$2400.00(-74.7%)
$29.00K(-16.4%)
Sep 2019
-
$9500.00(-26.4%)
$34.70K(-82.1%)
Jun 2019
-
$12.90K(+207.1%)
$193.50K(-45.1%)
Mar 2019
-
$4200.00(-48.1%)
$352.30K(-65.3%)
Dec 2018
$1.02M(+510.7%)
$8100.00(-95.2%)
$1.02M(-2.0%)
Sep 2018
-
$168.30K(-2.0%)
$1.04M(+16.3%)
Jun 2018
-
$171.70K(-74.3%)
$891.00K(+14.7%)
Mar 2018
-
$667.50K(+2217.7%)
$776.90K(+367.2%)
Dec 2017
$166.30K(-24.6%)
$28.80K(+25.2%)
$166.30K(-6.9%)
Sep 2017
-
$23.00K(-60.1%)
$178.70K(-35.0%)
Jun 2017
-
$57.60K(+1.2%)
$275.10K(-0.8%)
Mar 2017
-
$56.90K(+38.1%)
$277.20K(+25.8%)
Dec 2016
$220.60K
$41.20K(-65.5%)
$220.40K(+11.7%)
Sep 2016
-
$119.40K(+100.0%)
$197.40K(+119.3%)
Jun 2016
-
$59.70K(>+9900.0%)
$90.00K(+75.8%)
DateAnnualQuarterlyTTM
Mar 2016
-
$100.00(-99.5%)
$51.20K(-40.8%)
Dec 2015
$86.50K(-6.3%)
$18.20K(+51.7%)
$86.50K(+26.6%)
Sep 2015
-
$12.00K(-42.6%)
$68.30K(-1.4%)
Jun 2015
-
$20.90K(-41.0%)
$69.30K(-23.5%)
Mar 2015
-
$35.40K(>+9900.0%)
$90.60K(-1.7%)
Dec 2014
$92.30K(+9.1%)
$0.00(-100.0%)
$92.20K(0.0%)
Sep 2014
-
$13.00K(-69.2%)
$92.20K(-1.1%)
Jun 2014
-
$42.20K(+14.1%)
$93.20K(-3.0%)
Mar 2014
-
$37.00K(>+9900.0%)
$96.10K(+13.6%)
Dec 2013
$84.60K(+18.5%)
$0.00(-100.0%)
$84.60K(0.0%)
Sep 2013
-
$14.00K(-69.0%)
$84.60K(+19.8%)
Jun 2013
-
$45.10K(+76.9%)
$70.60K(+176.9%)
Mar 2013
-
$25.50K(>+9900.0%)
$25.50K(-64.3%)
Dec 2011
$71.40K(-80.9%)
$0.00(-100.0%)
$71.50K(-41.2%)
Sep 2011
-
$41.10K(+35.2%)
$121.50K(+74.6%)
Jun 2011
-
$30.40K(-39.2%)
$69.60K(-81.4%)
Dec 2010
$374.60K(-63.6%)
$50.00K(-563.0%)
$374.60K(-301.9%)
Sep 2010
-
-$10.80K(-119.3%)
-$185.50K(-147.1%)
Jun 2010
-
$55.90K(-80.0%)
$393.90K(-66.0%)
Mar 2010
-
$279.50K(-154.8%)
$1.16M(+12.4%)
Dec 2009
$1.03M(+102.1%)
-$510.10K(-189.7%)
$1.03M(-35.4%)
Sep 2009
-
$568.60K(-30.6%)
$1.59M(+39.7%)
Jun 2009
-
$818.90K(+438.8%)
$1.14M(+106.0%)
Mar 2009
-
$152.00K(+181.0%)
$554.00K(+8.8%)
Dec 2008
$509.30K(-42.3%)
$54.10K(-53.4%)
$509.40K(+11.9%)
Sep 2008
-
$116.10K(-49.9%)
$455.30K(+34.2%)
Jun 2008
-
$231.80K(+115.8%)
$339.20K(+215.8%)
Mar 2008
-
$107.40K(-56.6%)
$107.40K(-89.6%)
Dec 2007
$882.30K(+12.2%)
-
-
Mar 2007
-
$247.30K(-21.0%)
$1.03M(+31.4%)
Dec 2006
$786.50K
$313.20K(-33.8%)
$786.50K(+66.2%)
Sep 2006
-
$473.30K
$473.30K

FAQ

  • What is the all time high annual CAPEX for Altimmune, Inc.?
  • What is the all time high quarterly CAPEX for Altimmune, Inc.?
  • What is the all time high TTM CAPEX for Altimmune, Inc.?

What is the all time high annual CAPEX for Altimmune, Inc.?

Altimmune, Inc. all-time high annual capital expenditures is $12.31M

What is the all time high quarterly CAPEX for Altimmune, Inc.?

Altimmune, Inc. all-time high quarterly capital expenditures is $7.77M

What is the all time high TTM CAPEX for Altimmune, Inc.?

Altimmune, Inc. all-time high TTM capital expenditures is $12.31M
On this page